Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02737579 · ClinicalTrials.gov registry record · NA

XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization

A NA study of Congenital Heart Defect, sponsored by Joshua Kanter.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT02737579: Completed NA study of Congenital Heart Defect, sponsored by Joshua Kanter.

NCT02737579 is a NA study of Congenital Heart Defect that has completed, run by Joshua Kanter. The registered enrollment target is 27 participants, below the 105-participant average among 4 other Congenital Heart Defect trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02737579, a NA study of Congenital Heart Defect, has completed, sponsored by Joshua Kanter.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the use of x-ray fused with MR images as an imaging tool to help guide catheter tools during diagnostic and therapeutic cardiac catheterization procedures.

Primary Outcome

Comparisons with data from historical controls undergoing matched invasive cardiology procedures at Children's National Medical Center

Conditions Studied

Interventions

  • PROCEDURE XFM guidance

Study Locations (1)

District of Columbia

  • Children's National Health System - Washington D.C.

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2013-07-23
Est. Completion 2022-05-27
Phase NA
Joshua Kanter

1 total trials

What the finished NCT02737579 record still lists

NCT02737579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 105-participant average among 4 other Congenital Heart Defect trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Congenital Heart Defect appearing as the primary indexed condition, and to 1 intervention - of which XFM guidance is the first listed.

NCT02737579 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT02737579 about?

NCT02737579 is a clinical study titled "XFM: (X-ray Fused With MRI) Guided Cardiac Catheterization". This study will evaluate the use of x-ray fused with MR images as an imaging tool to help guide catheter tools during diagnostic and therapeutic cardiac catheterization procedures.

What is the current status of trial NCT02737579?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2013-07-23. Estimated completion is 2022-05-27.

What conditions does trial NCT02737579 study?

This clinical trial studies the following conditions: Congenital Heart Defect.

What interventions are being tested in trial NCT02737579?

The interventions under investigation include: XFM guidance (PROCEDURE).

Who is sponsoring clinical trial NCT02737579?

This trial is sponsored by Joshua Kanter, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02737579 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Defect

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02737579, the US trial registry maintained by the National Library of Medicine. NCT02737579 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.